IFNA1 and congenital rubella syndrome: In vitro experiments utilizing xenograft models of hematologic malignancy and serum samples obtained from patients who developed clinically significant CRS demonstrated that IFN-ɣ inhibition and deletion resulted in decreased macrophage activation and proinflammatory cytokine production, as well as reduced immune checkpoint expression.